DAA1395 |
expressed sequence AU020206 |
Molecular |
hippocampus |
Mouse |
AU020206 |
10.0% Increase Gene Expression Level |
|
DAA1393 |
progressive ankylosis |
Molecular |
hippocampus |
Mouse |
Ank |
1.0% Increase Gene Expression Level |
|
DAA2361 |
major histocompatibility complex, class II, DR beta 4 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB4 |
177.7% Increase Gene Expression Level |
|
DAA2141 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
Molecular |
hippocampus |
Human |
FCGR1B |
434.2% Increase Gene Expression Level |
|
DAA2299 |
chemokine (C-X-C motif) ligand 5 increases with age |
Molecular |
hippocampus |
Human |
CXCL5 |
64.9% Increase Gene Expression Level |
|
DAA2301 |
chemokine (C-X-C motif) ligand 16 increases with age |
Molecular |
hippocampus |
Human |
CXCL16 |
100.6% Increase Gene Expression Level |
|
DAA2155 |
Major histocompatibility complex, class II, DQ alpha 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DQA1 |
496.7% Increase Gene Expression Level |
|
DAA2277 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
Molecular |
hippocampus |
Human |
FCGR2A |
316.4% Increase Gene Expression Level |
|
DAA2300 |
chemokine (C-X-C motif) ligand 12 decreases with age |
Molecular |
hippocampus |
Human |
CXCL12 |
30.9% Decrease Gene Expression Level |
|
DAA2298 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
hippocampus |
Human |
CX3CL1 |
31.6% Decrease Gene Expression Level |
|
DAA2160 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
hippocampus |
Human |
FCGR3B |
647.0% Increase Gene Expression Level |
|
DAA2296 |
Chemokine (C-C motif) receptor 1 increases with age |
Molecular |
hippocampus |
Human |
CCR1 |
182.5% Increase Gene Expression Level |
|
DAA2297 |
chemokine (C-C motif) receptor 1 increases with age |
Molecular |
hippocampus |
Human |
CCR1 |
93.8% Increase Gene Expression Level |
|
DAA2278 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
hippocampus |
Human |
FCGR3B |
80.8% Increase Gene Expression Level |
|
DAA1420 |
programmed cell death 4 |
Molecular |
hippocampus |
Mouse |
Pdcd4 |
2.0% Increase Gene Expression Level |
|
DAA1433 |
Sec61 alpha 1 subunit (S. cerevisiae) |
Molecular |
hippocampus |
Mouse |
Sec61a1 |
1.0% Decrease Gene Expression Level |
|
DAA2273 |
CD163 molecule increases with age |
Molecular |
hippocampus |
Human |
CD163 |
552.3% Increase Gene Expression Level |
|
DAA1443 |
tubulin, gamma 1 |
Molecular |
hippocampus |
Mouse |
Tubg1 |
4.0% Decrease Gene Expression Level |
|
DAA1412 |
HtrA serine peptidase 1 |
Molecular |
hippocampus |
Mouse |
Htra1 |
2.0% Increase Gene Expression Level |
|
DAA1421 |
pyruvate dehydrogenase kinase, isoenzyme 4 |
Molecular |
hippocampus |
Mouse |
Pdk4 |
6.0% Increase Gene Expression Level |
|
DAA1411 |
general transcription factor II I |
Molecular |
hippocampus |
Mouse |
Gtf2i |
1.0% Decrease Gene Expression Level |
|
DAA1410 |
glial fibrillary acidic protein |
Molecular |
hippocampus |
Mouse |
Gfap |
4.0% Increase Gene Expression Level |
|
DAA1425 |
glutaminyl-tRNA synthase (glutamine-hydrolyzing)-like 1 |
Molecular |
hippocampus |
Mouse |
Qrsl1 |
3.0% Decrease Gene Expression Level |
|
DAA1409 |
growth arrest specific 5 |
Molecular |
hippocampus |
Mouse |
Gas5 |
2.0% Increase Gene Expression Level |
|
DAA2360 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
hippocampus |
Human |
HLA-DRB1 |
204.2% Increase Gene Expression Level |
|